These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 22566040)

  • 1. The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic review.
    Treglia G; Giovannini E; Di Franco D; Calcagni ML; Rufini V; Picchio M; Giordano A
    Ann Nucl Med; 2012 Jul; 26(6):451-61. PubMed ID: 22566040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer].
    García JR; Soler M; Blanch MA; Ramírez I; Riera E; Lozano P; Pérez X; Delgado E; Carrio I; Lomeña F
    Rev Esp Med Nucl; 2009; 28(3):95-100. PubMed ID: 19558948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic role of radiolabelled choline PET or PET/CT in hepatocellular carcinoma: a systematic review and meta-analysis.
    Bertagna F; Bertoli M; Bosio G; Biasiotto G; Sadeghi R; Giubbini R; Treglia G
    Hepatol Int; 2014 Oct; 8(4):493-500. PubMed ID: 26202754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.
    Tian M; Zhang H; Oriuchi N; Higuchi T; Endo K
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1064-72. PubMed ID: 15014903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A literature review of 18F-fluoride PET/CT and 18F-choline or 11C-choline PET/CT for detection of bone metastases in patients with prostate cancer.
    Wondergem M; van der Zant FM; van der Ploeg T; Knol RJ
    Nucl Med Commun; 2013 Oct; 34(10):935-45. PubMed ID: 23903557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-18 FDG in conjunction with 11C-choline PET/CT in the diagnosis of hepatocellular carcinoma.
    Wu HB; Wang QS; Li BY; Li HS; Zhou WL; Wang QY
    Clin Nucl Med; 2011 Dec; 36(12):1092-7. PubMed ID: 22064078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 18F-FDG and 11C-choline PET/CT for detecting recurrences in patients with nonsquamous cell head and neck malignancies.
    Ito K; Yokoyama J; Kubota K; Morooka M
    Nucl Med Commun; 2010 Nov; 31(11):931-7. PubMed ID: 20827227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon-11 choline positron emission tomography in musculoskeletal tumors: comparison with fluorine-18 fluorodeoxyglucose positron emission tomography.
    Yanagawa T; Watanabe H; Inoue T; Ahmed AR; Tomiyoshi K; Shinozaki T; Oriuchi N; Endo K; Takagishi K
    J Comput Assist Tomogr; 2003; 27(2):175-82. PubMed ID: 12703009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular imaging of brain tumors with radiolabeled choline PET.
    Calabria FF; Barbarisi M; Gangemi V; Grillea G; Cascini GL
    Neurosurg Rev; 2018 Jan; 41(1):67-76. PubMed ID: 27230829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of ¹¹C-choline imaging as a supplement to F-18 FDG PET imaging for detection of thyroid carcinoma.
    Wu HB; Wang QS; Wang MF; Li HS
    Clin Nucl Med; 2011 Feb; 36(2):91-5. PubMed ID: 21220968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literature.
    Mertens K; Slaets D; Lambert B; Acou M; De Vos F; Goethals I
    Eur J Nucl Med Mol Imaging; 2010 Nov; 37(11):2188-93. PubMed ID: 20544193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography for radiation treatment planning.
    Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
    Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of (11)C-choline and (18)F-choline PET/CT for management of patients with prostate cancer.
    von Eyben FE; Kairemo K
    Nucl Med Commun; 2014 Mar; 35(3):221-30. PubMed ID: 24240194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study.
    Rodado-Marina S; Coronado-Poggio M; García-Vicente AM; García-Garzón JR; Alonso-Farto JC; de la Jara AC; Maldonado-Suárez A; Rodríguez-Fernández A
    BJU Int; 2015 Jun; 115(6):874-83. PubMed ID: 25307619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative studies using positron emission tomography (PET) for the diagnosis and therapy planning of oncological patients.
    Dimitrakopoulou-Strauss A; Strauss L
    Hell J Nucl Med; 2006; 9(1):10-21. PubMed ID: 16617388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic relevance of choline-PET / CT in patients with prostate cancer].
    Zengerling F; Schrader AJ; Schrader M; Jentzmik F
    Aktuelle Urol; 2012 Jan; 43(1):49-54. PubMed ID: 21769763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cell proliferation, protein, and glucose metabolism in musculoskeletal tumors in a PET study.
    Tian M; Zhang H; Endo K
    J Biomed Biotechnol; 2011; 2011():807929. PubMed ID: 21738405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
    Li DL; Xu YK; Wang QS; Wu HB; Li HS
    Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
    Ho CL; Chen S; Yeung DW; Cheng TK
    J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.